Form 4: Astronics Corp. CEO Peter Gundermann Reports Stock Transactions
SEC Form 4
Astronics Corp. CEO Peter J. Gundermann reports acquisition and disposal of company stock and derivative securities, including stock bonuses, tax withholdings, and 401(k) contributions.
Summary
- Peter J. Gundermann, the President/CEO of Astronics Corp., filed a Form 4 detailing changes in beneficial ownership of the company's securities.
- On May 10, 2024, Gundermann acquired 438 shares of common stock as a bonus for Q1 2024, paid in shares instead of cash.
- Also on May 10, 2024, 107 shares were withheld to cover applicable withholding taxes related to the stock bonus award.
- On May 13, 2024, Gundermann acquired 252.634 shares through the issuer's contribution to his 401(k) plan at a price of $18.89 per share.
- Gundermann directly owns 74,983.608 shares of $.01 PV Com Stk.
- Gundermann directly owns 743,493 shares of $.01 PV CL B STK.
- The report also details various options and restricted stock units (RSUs) held by Gundermann, with vesting conditions tied to Astronics Corp.'s average annual adjusted EBITDA for different periods.
Sentiment
Score: 6
Explanation: The document is a routine filing and doesn't contain overtly positive or negative information. The CEO's stock acquisitions are mildly positive, suggesting confidence, but the tax withholdings are neutral.
Positives
- The CEO's acquisition of shares as a bonus could be seen as a positive signal, indicating confidence in the company's performance.
- Regular contributions to the CEO's 401(k) in company stock align his interests with those of the shareholders.
Negatives
- The withholding of shares for taxes reduces the immediate benefit of the stock bonus for the CEO.
Risks
- The vesting of restricted stock units is contingent on the company achieving specific EBITDA targets, which introduces performance-related risk.
- Fluctuations in the company's stock price could impact the value of the CEO's holdings and potentially influence decision-making.
Future Outlook
The vesting of a significant portion of the CEO's compensation is tied to the company's future EBITDA performance, incentivizing him to drive profitability.
Industry Context
Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders. The specific terms and conditions, such as EBITDA-based vesting, vary depending on the company and industry.
Comparison to Industry Standards
- Many companies in the aerospace and defense industry, such as Boeing, Lockheed Martin, and Raytheon Technologies, use a mix of salary, stock options, and performance-based bonuses to compensate their executives.
- The use of EBITDA as a performance metric is common, as it reflects the company's operational profitability.
- Vesting schedules for restricted stock units typically range from three to five years, which is consistent with Astronics' approach.
Stakeholder Impact
- Shareholders may view the CEO's stock acquisitions as a positive sign of alignment with their interests.
- Employees participating in the 401(k) plan may be affected by the company's contributions in the form of company stock.
Key Dates
| Date | Description |
|---|---|
| 12/14/2017 | Date of option grant with exercise price of $31.76 |
| 12/12/2018 | Date of option grant with exercise price of $35.61 |
| 01/01/2020 | Start date for EBITDA performance period related to restricted stock units. |
| 12/09/2020 | Date of option grant with exercise price of $30.04 |
| 01/01/2021 | Start date for EBITDA performance period related to restricted stock units. |
| 01/22/2022 | Date of option grant with exercise price of $14.45 |
| 12/09/2022 | Date of option grant with exercise price of $11.13 |
| 01/01/2022 | Start date for EBITDA performance period related to restricted stock units. |
| 12/31/2022 | Vesting date for restricted stock units based on EBITDA performance from January 1, 2020 to December 31, 2022. |
| 01/01/2023 | Start date for EBITDA performance period related to restricted stock units. |
| 12/16/2023 | Date of option grant with exercise price of $9.74 |
| 12/31/2023 | Vesting date for restricted stock units based on EBITDA performance from January 1, 2021 to December 31, 2023. |
| 01/01/2024 | Start date for EBITDA performance period related to restricted stock units. |
| 05/10/2024 | Date of stock bonus award and tax withholding. |
| 05/13/2024 | Date of issuer's contribution to the reporting person's 401(k) plan. |
| 05/14/2024 | Date of Form 4 filing. |
| 12/07/2024 | Date of option grant with exercise price of $15.15 |
| 02/24/2025 | Potential vesting date for restricted stock units based on EBITDA performance from January 1, 2022 to December 31, 2024. |
| 02/23/2026 | Potential vesting date for restricted stock units based on EBITDA performance from January 1, 2023 to December 31, 2025. |
| 02/23/2027 | Potential vesting date for restricted stock units based on EBITDA performance from January 1, 2024 to December 31, 2026. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.